Supera Stent Addresses Growing Need in the U.S. to Treat People with Blocked Blood Vessels and Restore Blood Flow in the Upper Leg Abbott Park, Illinois — Abbott today announced that its Supera® ...

SUPERB Trial and SUPERA 500 Registry Both Demonstrate Highest Reported Patency Rates and Zero Fracture Rates Data Presented at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) ...

WEBSTER, Texas, Sept. 27, 2012 /PRNewswire/ -- IDEV Technologies, Inc. (IDEV), an emerging global innovator in peripheral devices, today announced that Private Healthcare Australia has granted the ...

LAS VEGAS and WEBSTER, Texas, Oct. 10, 2012 /PRNewswire/ -- IDEV Technologies, Inc. (IDEV) today announced positive clinical outcomes for its SUPERB pivotal clinical trial of its SUPERA® Peripheral ...

Abbott Vascular today announced that the FDA has approved its Supera Peripheral Stent System to treat blocked blood vessels in the upper leg due to peripheral arterial disease. The stent is indicated ...

Abbott ($ABT) is promoting the health economics of its Supera Stent for peripheral artery disease, pointing to a yet-to-be-published study which found that the device ...

The FDA approval was supported by encouraging data from the SUPERB trial which showed that the Supera stent was highly effective in opening up blocked blood vessels in the upper leg, even in difficult ...

IDEV Technologies, Inc. today announced the publication of 24-month data on the company's SUPERA® stent. The data was published in the December issue of the Journal of Endovascular Therapy, and ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — A peripheral stent was safe and effective for treatment of common femoral artery lesions at 12 ...

ABBOTT PARK, Ill., March 28, 2014 /PRNewswire/ -- Abbott today announced that its Supera ® Peripheral Stent System has received U.S. Food and Drug Administration (FDA) approval to treat people with ...

Abbott Laboratories ( ABT) received a boost for its vascular portfolio when it announced that the U.S. Food and Drug Administration (FDA) approved its Supera peripheral stent system for the treatment ...

MIAMI and WEBSTER, Texas, Oct. 22, 2012 /PRNewswire/ -- IDEV Technologies, Inc. (IDEV) today announced the presentation of consistent positive clinical outcomes of the SUPERA® Peripheral Stent System ...